Neepa Ray

728 total citations
14 papers, 493 citations indexed

About

Neepa Ray is a scholar working on Psychiatry and Mental health, Geriatrics and Gerontology and Epidemiology. According to data from OpenAlex, Neepa Ray has authored 14 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 4 papers in Geriatrics and Gerontology and 3 papers in Epidemiology. Recurrent topics in Neepa Ray's work include Schizophrenia research and treatment (8 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Chronic Disease Management Strategies (3 papers). Neepa Ray is often cited by papers focused on Schizophrenia research and treatment (8 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Chronic Disease Management Strategies (3 papers). Neepa Ray collaborates with scholars based in United States, Taiwan and South Africa. Neepa Ray's co-authors include Robert M. Hamer, T. Scott Stroup, Sandra L. Martin, Kathryn E. Moracco, Ziya Gizlice, Lawrence L. Kupper, Daniela Sotres‐Alvarez, Margaret Nusbaum, Margaret R. Helton and J. Steven Lamberti and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Journal of the American Geriatrics Society.

In The Last Decade

Neepa Ray

13 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neepa Ray United States 8 229 105 96 80 65 14 493
Robert Constantine United States 13 247 1.1× 59 0.6× 258 2.7× 10 0.1× 14 0.2× 33 546
Trupti Meher India 10 46 0.2× 107 1.0× 34 0.4× 25 0.3× 5 0.1× 19 311
Sarah Morgan‐Trimmer United Kingdom 12 120 0.5× 31 0.3× 87 0.9× 11 0.1× 8 0.1× 46 497
Senthil Amudhan India 10 147 0.6× 43 0.4× 109 1.1× 10 0.1× 9 0.1× 29 476
Miriam Mutambudzi United States 12 24 0.1× 54 0.5× 55 0.6× 16 0.2× 8 0.1× 32 395
Camillia K. Lui United States 16 20 0.1× 98 0.9× 187 1.9× 38 0.5× 14 0.2× 50 958
Ren-Hau Li Taiwan 14 30 0.1× 22 0.2× 116 1.2× 26 0.3× 12 0.2× 30 507
Ingeborg Eriksson Sweden 9 33 0.1× 233 2.2× 58 0.6× 70 0.9× 4 0.1× 10 665
John‐Kåre Vederhus Norway 16 89 0.4× 36 0.3× 120 1.3× 6 0.1× 10 0.2× 51 589

Countries citing papers authored by Neepa Ray

Since Specialization
Citations

This map shows the geographic impact of Neepa Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neepa Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neepa Ray more than expected).

Fields of papers citing papers by Neepa Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neepa Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neepa Ray. The network helps show where Neepa Ray may publish in the future.

Co-authorship network of co-authors of Neepa Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Neepa Ray. A scholar is included among the top collaborators of Neepa Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neepa Ray. Neepa Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Ray, Neepa, Chelsea P. Renfro, Jan Busby‐Whitehead, et al.. (2024). Impact of STEADI-Rx: A Community Pharmacy-Based Fall Prevention Intervention. UNC Libraries. 1 indexed citations
2.
Gertner, Alex K., Ching-Ching Lin, Neepa Ray, et al.. (2023). Enhanced Primary Care for People With Serious Mental Illness. The Journal of Clinical Psychiatry. 84(3). 3 indexed citations
3.
Gertner, Alex K., Ching-Ching Lin, Neepa Ray, et al.. (2021). Effect of Enhanced Primary Care for People with Serious Mental Illness on Service Use and Screening. Journal of General Internal Medicine. 36(4). 970–977. 13 indexed citations
4.
Blalock, Susan J., Stefanie P. Ferreri, Chelsea P. Renfro, et al.. (2020). Impact of STEADI‐Rx : A Community Pharmacy‐Based Fall Prevention Intervention. Journal of the American Geriatrics Society. 68(8). 1778–1786. 18 indexed citations
5.
Rosenheck, Robert A., Joseph P. McEvoy, Marvin S. Swartz, et al.. (2020). Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia: A Randomized Clinical Trial. UNC Libraries. 4 indexed citations
6.
Turner, Kea, Justin G. Trogdon, Morris Weinberger, et al.. (2018). Testing the organizational theory of innovation implementation effectiveness in a community pharmacy medication management program: a hurdle regression analysis. Implementation Science. 13(1). 105–105. 24 indexed citations
7.
Hansen, Richard A., Matthew L. Maciejewski, Marisa Elena Domino, et al.. (2017). Continuity of medication management among adults with schizophrenia and comorbid cardiometabolic conditions. Journal of Pharmaceutical Health Services Research. 9(1). 13–20. 5 indexed citations
8.
Farley, Joel F., Richard A. Hansen, Marisa Elena Domino, et al.. (2016). Continuity of medication management in Medicaid patients with chronic comorbid conditions: An examination by mental health status. General Hospital Psychiatry. 45. 25–31. 6 indexed citations
9.
McEvoy, Joseph P., Matthew Byerly, Robert M. Hamer, et al.. (2014). Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia. JAMA. 311(19). 1978–1978. 104 indexed citations
10.
Stroup, T. Scott, Matthew Byerly, Henry A. Nasrallah, et al.. (2013). Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial. Schizophrenia Research. 146(1-3). 190–195. 26 indexed citations
11.
Jarskog, L. Fredrik, Robert M. Hamer, Diane Catellier, et al.. (2013). Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder. American Journal of Psychiatry. 170(9). 1032–1040. 98 indexed citations
13.
Martin, Sandra L., Neepa Ray, Daniela Sotres‐Alvarez, et al.. (2006). Physical and Sexual Assault of Women With Disabilities. Violence Against Women. 12(9). 823–837. 152 indexed citations
14.
Nusbaum, Margaret, Margaret R. Helton, & Neepa Ray. (2004). The changing nature of women’s sexual health concerns through the midlife years. Maturitas. 49(4). 283–291. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026